A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece

Study Identifier
PMOS GREC 2004 06
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Rheumatoid Arthritis
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    The objectives of the study are to observe and assess the long-term use, safety and efficacy of Humira (adalimumab), as prescribed by the rheumatologist in a normal clinical setting and in accordance with the terms of the European marketing authorization and to observe compliance of patients with the prescribed treatment.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 30116
    A. Glyfada, Greece
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 47544
    Ag. Dimitrios, Athens, Greece, 17121
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 47542
    Ag. Paraskevi, Athens, Greece, 15343
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 29915
    Alexandroupoli, Greece, 68100
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 30118
    Arta, Greece, 47100
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 29989
    Athens, Greece, 10444
    Status
    Not applicable
    Showing {first} - {last} of {total} Results